Review of vascularized bone marrow transplantation: Current status and future clinical applications

被引:22
作者
Gordon, Chad R.
Tai, Chau Y.
Suzuki, Hidetoshi
Strande, Louise F.
Ramsamooj, Rajendra
Matthews, Martha S.
Black, Kirby S.
Hewitt, Charles W.
机构
[1] Cooper Univ Hosp, Robert Wood Johnson Med Sch, Dept Surg, Div Surg Res, Camden, NJ 08103 USA
[2] Hamamatsu Univ Sch Med, Dept Anat 2, Hamamatsu, Shizuoka 43131, Japan
[3] Univ Calif Davis, Dept Pathol, Sacramento, CA 95817 USA
[4] Kennesaw State Univ, Dept Biotechnol, Kennesaw, GA USA
关键词
D O I
10.1002/micr.20367
中图分类号
R61 [外科手术学];
学科分类号
摘要
In this review, we examine the applicability of the vascularized bone marrow transplant (VBMT) as an alternative to conventional bone marrow transplantation (BMT). As a new surgical approach, the VBMT is unique by transplantation of the stromal environment that eliminates the need for an engraftment period, provides critical signaling and modulatory functions, and may potentiate tolerance induction. Thus far, VBMT studies have demonstrated an absence of graft-versus-host disease (GVHD) and robust engraftment into nonmanipulated as well as irradiated recipients with evidence of immunological tolerance. Further investigation is needed to determine the applicability of VBMT as an alternative to BMT. (C) 2007 Wiley-Liss, Inc. Microsurgery 27:348-353, 2007.
引用
收藏
页码:348 / 353
页数:6
相关论文
共 51 条
[1]  
APPELBAUM FR, 1978, BLOOD, V52, P85
[2]   Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease [J].
Balon, J ;
Halaburda, K ;
Bieniaszewska, M ;
Reichert, M ;
Bieniaszewski, L ;
Piekarska, A ;
Pawlowski, R ;
Hellmann, A .
BONE MARROW TRANSPLANTATION, 2005, 35 (11) :1083-1088
[3]   Transplantation of the bone marrow microenvironment leads to hematopoietic chimerism without cytoreductive conditioning [J].
Bingaman, AW ;
Waitze, SY ;
Alexander, DZ ;
Cho, HR ;
Lin, A ;
Tucker-Burden, C ;
Cowan, SR ;
Pearson, TC ;
Larsen, CP .
TRANSPLANTATION, 2000, 69 (12) :2491-2496
[4]   Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation [J].
Chung, NG ;
Jeong, DC ;
Park, SJ ;
Choi, BO ;
Cho, B ;
Kim, HK ;
Chun, CS ;
Won, JH ;
Han, CW .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 80 (04) :370-376
[5]  
Durlik M, 1998, Transpl Int, V11 Suppl 1, pS299
[6]   Microchimerism and rejection in clinical transplantation [J].
Elwood, ET ;
Larsen, CP ;
Maurer, MH ;
Routenberg, KL ;
Neylan, NF ;
Whelchel, JD ;
OBrien, DP ;
Pearson, TC .
LANCET, 1997, 349 (9062) :1358-1360
[7]  
Eto M, 1999, IMMUNOLOGY, V96, P440
[8]   No detectable microchimerism in long-term tolerant recipients of living-donor kidneys [J].
Garnier, JL ;
Touraine, JL ;
Gebuhrer, L .
TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) :1181-1181
[9]   DEVELOPMENT OF STABLE MIXED T-CELL CHIMERISM AND TRANSPLANTATION TOLERANCE WITHOUT IMMUNE MODULATION IN RECIPIENTS OF VASCULARIZED BONE-MARROW ALLOGRAFTS [J].
HEWITT, CW ;
RAMSAMOOJ, R ;
PATEL, MP ;
YAZDI, B ;
ACHAUER, BM ;
BLACK, KS .
TRANSPLANTATION, 1990, 50 (05) :766-772
[10]   COMPOSITE TISSUE (LIMB) ALLOGRAFTS IN RATS .3. DEVELOPMENT OF DONOR-HOST LYMPHOID CHIMERAS IN LONG-TERM SURVIVORS [J].
HEWITT, CW ;
BLACK, KS ;
DOWDY, SF ;
GONZALEZ, GA ;
ACHAUER, BM ;
MARTIN, DC ;
FURNAS, DW ;
HOWARD, EB .
TRANSPLANTATION, 1986, 41 (01) :39-43